Protective effects of cyclosporin-A in splanchnic artery occlusion shock
- PMID: 10807671
- PMCID: PMC1572071
- DOI: 10.1038/sj.bjp.0703310
Protective effects of cyclosporin-A in splanchnic artery occlusion shock
Abstract
Cyclosporin A (CsA) is an immunosuppressant drug that inhibits nitric oxide (NO) synthase induction in vascular smooth muscle cells. Splanchnic artery occlusion (SAO) shock is a lethal type of shock characterized by a marked vascular dysfunction in which the L-arginine/nitric oxide pathway plays an important role. We investigated whether CsA exerts protective effects in SAO shock by interfering with the L-arginine/nitric oxide pathway. Male anaesthetized rats (n=156) were subjected to clamping of the splanchnic arteries for 45 min. This surgical procedure resulted in an irreversible state of shock (SAO shock). Sham operated animals were used as controls. SAO shocked rats had a decreased survival (86+/-6 min, while sham shocked rats survived more than 240 min), marked hypotension, increased serum levels of TNF-alpha, enhanced plasma nitrite/nitrate concentrations (75+/-7.1 microM; sham shocked rats=1.6+/-0.5 microM) and enhanced inducible NO synthase (iNOS) protein induction and activity in the aorta. Moreover aortic rings from shocked rats showed a marked hyporeactivity to phenylephrine (PE, 1 nM - 10 microM). CsA (0.25, 0.5 and 1 mg kg(-1), 5 min after reperfusion) increased survival rate (SAO+CsA=236+/-9 min following the highest dose), reverted the marked hypotension, reduced plasma nitrite/nitrate concentration (11+/-5.2 microM following the highest dose), restored to control values the hyporeactivity to PE, and blunted iNOS protein induction and activity in aortic rings. The present data indicate that in an experimental rat model CsA may have antishock properties related to inhibition of L-arginine/nitric oxide pathway.
Figures



Similar articles
-
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.Br J Pharmacol. 1999 Oct;128(3):816-22. doi: 10.1038/sj.bjp.0702848. Br J Pharmacol. 1999. PMID: 10516667 Free PMC article.
-
Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.Br J Pharmacol. 1999 May;127(2):482-8. doi: 10.1038/sj.bjp.0702521. Br J Pharmacol. 1999. PMID: 10385249 Free PMC article.
-
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.Br J Pharmacol. 1994 Dec;113(4):1153-8. doi: 10.1111/j.1476-5381.1994.tb17118.x. Br J Pharmacol. 1994. PMID: 7889268 Free PMC article.
-
Effects of S-ethylisothiourea, a potent inhibitor of nitric oxide synthase, alone or in combination with a nitric oxide donor in splanchnic artery occlusion shock.Br J Pharmacol. 1996 Sep;119(1):23-8. doi: 10.1111/j.1476-5381.1996.tb15672.x. Br J Pharmacol. 1996. PMID: 8872352 Free PMC article.
-
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.Br J Pharmacol. 1999 May;127(2):498-504. doi: 10.1038/sj.bjp.0702528. Br J Pharmacol. 1999. PMID: 10385251 Free PMC article.
Cited by
-
Cyclosporine A--protection against microvascular hyperpermeability is calcineurin independent.Am J Surg. 2010 Apr;199(4):542-8. doi: 10.1016/j.amjsurg.2009.11.002. Am J Surg. 2010. PMID: 20359571 Free PMC article.
References
-
- AKITA K., DUSTING G.J., HICKEY H. Suppression of nitric oxide production by cyclosporin and FK506 in rat vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 1994;21:231–233. - PubMed
-
- ALTAVILLA D., BERLINGHIERI M.C., SEMINARA S., IANNELLO D., FOCA' A., MASTROENI P. Differential effects of bacterial lipopolysaccharide on superoxide anion production by macrophages from normal and tumor bearing rats. Immunopharmacology. 1989;17:99–105. - PubMed
-
- BUSSE R., MULSCH A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS. Lett. 1990;275:87–90. - PubMed
-
- CAPUTI A.P., ROSSI F., CARNEY K., BREZENOFF H.E. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J. Pharmacol. Exp. Ther. 1980;215:309–316. - PubMed
-
- CLIPSTONE N.A., CRABTREE G.R. Calcineurin is a key signaling enzyme in lymphocyte activation and the target of immunosuppressive drugs cyclosporin A and FK506. Ann. NY. Acad. Sci. 1993;696:20–30. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical